title: New medications for treatment of chronic hepatitis C.
abstract: Treating chronic hepatitis C is crucial to preventing long-term complications such as cirrhosis and liver cancer. New treatments may improve response rates, but the high cost of therapy is a major concern. This article reviews two of these new treatments, sofosbuvir and simeprevir.
authors.affiliation: Melissa Murfin is an assistant professor in the PA program at Elon (N.C.) University. The author has disclosed no potential conflicts of interest, financial or otherwise.
authors.forename: Melissa
authors.initials: M
authors.lastname: Murfin
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000069616:Simeprevir / Q000627:therapeutic use*; D000069474:Sofosbuvir / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D000069616:Simeprevir; D000069474:Sofosbuvir